{"nct_id":"NCT03703297","title":"Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2018-09-27","start_date_type":"ACTUAL","primary_completion_date":"2024-01-15","primary_completion_date_type":"ACTUAL","completion_date":"2026-03-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}